Inmune Bio (INMB) Receivables - Net (2019 - 2025)
Historic Receivables - Net for Inmune Bio (INMB) over the last 6 years, with Q3 2025 value amounting to $1.7 million.
- Inmune Bio's Receivables - Net rose 5365.19% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 5365.19%. This contributed to the annual value of $1.2 million for FY2024, which is 3800.52% down from last year.
- Per Inmune Bio's latest filing, its Receivables - Net stood at $1.7 million for Q3 2025, which was up 5365.19% from $2.0 million recorded in Q2 2025.
- Inmune Bio's Receivables - Net's 5-year high stood at $3.1 million during Q2 2024, with a 5-year trough of $100000.0 in Q1 2021.
- Over the past 4 years, Inmune Bio's median Receivables - Net value was $1.2 million (recorded in 2024), while the average stood at $1.2 million.
- In the last 5 years, Inmune Bio's Receivables - Net tumbled by 9655.17% in 2021 and then surged by 5365.19% in 2025.
- Inmune Bio's Receivables - Net (Quarter) stood at $100000.0 in 2021, then skyrocketed by 1805.0% to $1.9 million in 2023, then tumbled by 38.01% to $1.2 million in 2024, then skyrocketed by 44.28% to $1.7 million in 2025.
- Its last three reported values are $1.7 million in Q3 2025, $2.0 million for Q2 2025, and $1.3 million during Q1 2025.